Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma

Overview of attention for article published in Frontiers in immunology, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 21 X users

patent: 1 patent

Citations

dimensions_citation: 66 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

PRE-MEDICATION AND IMPROVED TREATMENT REGIMEN

Application WO-2024083959-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.